XML 63 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 16 - Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Notes Tables  
Stock-based compensation expense

​

​

​

​

​

​

​

​

​

​

​

​

    

2021

    

2020

    

2019

​

​

(dollars in thousands)

​

​

​

​

​

​

​

​

​

​

Stock options

​

$

270

​

$

297

​

$

475

Restricted stock awards

​

​

1,864

​

​

1,619

​

​

1,850

Stock purchase plan

​

 

218

​

 

234

​

 

144

​

​

$

2,352

​

$

2,150

​

$

2,469

​

​

​

​

​

​

​

​

​

​

Summary of the stock option plans

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 

​

​

2021

​

2020

​

2019

​

​

​

​

​

Weighted

​

​

​

​

Weighted

​

​

​

​

Weighted

​

​

​

​

​

Average

​

​

​

​

Average

​

​

​

​

Average

​

​

​

​

​

Exercise

​

​

​

​

Exercise

​

​

​

​

Exercise

​

    

Shares

    

Price

    

Shares

    

Price

    

Shares

    

Price

Outstanding, beginning

​

​

407,763

​

$

22.24

​

​

426,913

​

$

20.14

​

​

469,572

​

$

18.52

Granted

 

​

22,150

​

 

43.61

 

​

23,350

​

 

39.12

 

​

20,200

​

 

36.00

Exercised

 

​

(60,317)

​

 

15.76

 

​

(41,650)

​

 

10.67

 

​

(59,393)

​

 

12.11

Forfeited

 

​

(1,598)

​

 

38.50

 

​

(850)

​

 

19.94

 

​

(3,466)

​

 

31.59

Outstanding, ending

 

​

367,998

​

 

24.46

 

​

407,763

​

 

22.24

 

​

426,913

​

 

20.14

​

 

​

  

​

 

  

 

​

  

​

 

  

 

​

  

​

 

  

Exercisable, ending

 

​

318,266

​

 

  

 

​

354,899

​

 

  

 

​

365,084

​

 

  

​

 

​

  

​

 

  

 

​

  

​

 

  

 

​

  

​

 

  

Weighted average fair value per option granted

​

$

10.85

​

 

  

​

$

10.07

​

 

  

​

$

11.29

​

 

  

Summary of options outstanding

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Options Outstanding

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

Options Exercisable

​

​

​

​

Average

​

Weighted

​

​

​

Weighted

​

​

​

​

Remaining

​

Average

​

​

​

Average

Range of

​

Number

​

Contractual

​

Exercise

​

Number

​

Exercise

Exercise Prices

    

Outstanding

    

Life

    

Price

    

Exercisable

    

Price

$9.30

​

29,406

​

0.08

​

$

9.30

​

29,406

​

$

9.30

$15.50 to $15.65

 

64,106

 

1.25

​

 

15.64

 

64,066

​

 

15.64

$17.10 to $18.00

 

110,499

 

2.57

​

 

17.31

 

110,459

​

 

17.31

$22.64 to $29.77

 

55,216

 

4.20

​

 

22.83

 

53,716

​

 

22.64

$36.00 to $41.95

 

37,834

 

7.66

​

 

38.25

 

14,360

​

 

37.84

$42.65 to $48.50

 

70,937

 

6.59

​

 

43.78

 

46,259

​

 

43.84

​

 

367,998

 

  

​

 

  

 

318,266

​

 

  

​

 

​

​

​

​

​

​

​

​

​

 

  

Summary of changes in nonvested restricted stock awards

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 

​

    

2021

    

2020

    

2019

Outstanding, beginning

​

​

102,489

​

​

106,826

​

​

64,099

Granted*

​

 

38,360

​

 

34,559

​

 

85,961

Released

​

 

(43,691)

​

 

(37,296)

​

 

(37,624)

Forfeited

​

 

(51)

​

 

(1,600)

​

 

(5,610)

Outstanding, ending

​

​

97,107

​

​

102,489

​

​

106,826

​

​

​

​

​

​

​

​

​

​

Weighted average fair value per share granted

​

$

45.18

​

$

39.39

​

$

20.14

​

​

​

​

​

​

​

​

​

​

​

*  At December 31, 2021, includes 12,412 shares of restricted stock, 25,948 restricted stock units.

At December 31, 2020, includes 8,913 shares of restricted stock and 25,646 restricted stock units.

At December 31, 2019, includes 18,634 shares of restricted stock, 49,269 restricted stock units and 18,058 restricted stock units.

​

Schedule of Stock purchase plan

​

​

​

​

​

​

​

​

​

​

​

​

    

2021

    

2020

    

2019

Shares granted

 

​

28,396

 

​

38,738

 

​

29,882

Shares purchased

 

​

30,543

 

​

37,114

 

​

28,775

Weighted average fair value per share granted

​

$

7.67

​

$

6.03

​

$

4.81